Respiratory infections and tuberculosis

Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell
Jason L.N. Girkin, Steven Maltby, Nathan W. Bartlett

European Respiratory Review Jun 2022, 31 (164) 210274; DOI: 10.1183/16000617.0274-2021
COVID-19 and tuberculosis: the double whammy of respiratory pathogens
Mohd Shariq, Javaid A. Sheikh, Neha Quadir, Neha Sharma, Seyed E. Hasnain, Nasreen Z. Ehtesham

European Respiratory Review Jun 2022, 31 (164) 210264; DOI: 10.1183/16000617.0264-2021
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group
Solomon Tibebu Melkie, Lilibeth Arias, Chiara Farroni, Mateja Jankovic Makek, Delia Goletti, Cristina Vilaplana

European Respiratory Review Mar 2022, 31 (163) 210218; DOI: 10.1183/16000617.0218-2021
Post-acute COVID-19 syndrome
David Montani, Laurent Savale, Nicolas Noel, Olivier Meyrignac, Romain Colle, Matthieu Gasnier, Emmanuelle Corruble, Antoine Beurnier, Etienne-Marie Jutant, Tài Pham, Anne-Lise Lecoq, Jean-François Papon, Samy Figueiredo, Anatole Harrois, Marc Humbert, Xavier Monnet

European Respiratory Review Mar 2022, 31 (163) 210185; DOI: 10.1183/16000617.0185-2021
Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments
Kartik Kumar, Charles L. Daley, David E. Griffith, Michael R. Loebinger

European Respiratory Review Mar 2022, 31 (163) 210212; DOI: 10.1183/16000617.0212-2021
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Ruben J. Mylvaganam, Joseph I. Bailey, Jacob I. Sznajder, Marc A. Sala

European Respiratory Review Dec 2021, 30 (162) 210194; DOI: 10.1183/16000617.0194-2021
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline
Megan L. Crichton, Pieter C. Goeminne, Krizia Tuand, Thomas Vandendriessche, Thomy Tonia, Nicolas Roche, James D. Chalmers

European Respiratory Review Dec 2021, 30 (162) 210171; DOI: 10.1183/16000617.0171-2021
COVID-19 pneumonia: pathophysiology and management
Luciano Gattinoni, Simone Gattarello, Irene Steinberg, Mattia Busana, Paola Palermo, Stefano Lazzari, Federica Romitti, Michael Quintel, Konrad Meissner, John J. Marini, Davide Chiumello, Luigi Camporota

European Respiratory Review Dec 2021, 30 (162) 210138; DOI: 10.1183/16000617.0138-2021
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
Andrea Sauer, Konrad Peukert, Christian Putensen, Christian Bode

European Respiratory Review Dec 2021, 30 (162) 210093; DOI: 10.1183/16000617.0093-2021
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections
James D. Chalmers, Jakko van Ingen, Roald van der Laan, Jean-Louis Herrmann

European Respiratory Review Sep 2021, 30 (161) 210010; DOI: 10.1183/16000617.0010-2021

Main menu

User menu

Search

Respiratory infections and tuberculosis

Pages

Contact us